发明名称 |
Oxadiazoles as modulators of metabotropic glutamate receptor-5 |
摘要 |
Oxadiazoles compounds of formula (I), wherein P, Q, X1, X2, X3, X4, R, R1, R2, R3, R4, R5, R6, R7, m, n, o, p and q are defined as in the specification, a process for their preparation and new intermediates prepared therein and pharmaceutical formulations containing these compounds are disclosed. These compounds of formula (I) are suitable as modulators of metabotropic glutamate receptor-5 (mGluR5) and are used for treating mGluR5 receptor mediated disorders such as neurological disorders, psychiatric disorders and chronic and acute pain disorders.
|
申请公布号 |
NZ538339(A) |
申请公布日期 |
2007.01.26 |
申请号 |
NZ20030538339 |
申请日期 |
2003.08.08 |
申请人 |
ASTRAZENECA AB;NPS PHARMACEUTICALS, INC |
发明人 |
WENSBO, DAVID;XIN, TAO;STEFANAC, TOMISLAV;ARORA, JALAJ;EDWARDS, LOUISE;ISAAC, METHVIN;SLASSI, ABDELMALIK;STORMANN, THOMAS M;MCLEOD, DONALD A;KERS, ANNIKA;MALMBERG, JOHAN;OSCARSSON, KARIN |
分类号 |
A61P25/00;C07D261/08;C07D261/14;C07D271/06;C07D271/07;C07D271/10;C07D271/107;C07D271/113;C07D413/04;C07D413/06;C07D413/10;C07D413/14;(IPC1-7):A61K31/424 |
主分类号 |
A61P25/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|